(Q44393739)

2 December 2017

A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia (English)

1 reference

2 December 2017

0 references

1 reference

placebo-controlled trial

1 reference

1 reference

Ciaran Mulholland

1

1 reference

2 December 2017

Gerard Lynch

series ordinal

2

1 reference

2 December 2017

David J King

series ordinal

3

1 reference

2 December 2017

Stephen J Cooper

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of Psychopharmacology

2 December 2017

1 reference

2 December 2017

17

1 reference

2 December 2017

1

1 reference

2 December 2017

107-112

1 reference

Reasons for substance use in schizophrenia.

2 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

A double-blind study of adjunctive sertraline in haloperidol-stabilized patients with chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

Antidepressant Usage in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

Relationship Between Cognitive Defect, Affect Response and Community Adjustment in Chronic Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

Use of Antidepressant Drugs in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

What do depression rating scales measure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

An open trial of adjunctive sertraline in the treatment of chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001713

10.1177/0269881103017001713

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference